JEFFREY F EISENBERG Insider Trading $XBIO Xenetic Biosciences, Inc.
Get free email notifications about insider trading for JEFFREY F EISENBERG.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of JEFFREY F EISENBERG. JEFFREY F EISENBERG is Executive Vice President in NOVEN PHARMACEUTICALS INC ($NOVN) and Executive VP and Interim CEO in NOVEN PHARMACEUTICALS INC ($NOVN) and Sr. VP - Strategic Alliances in NOVEN PHARMACEUTICALS INC ($NOVN) and VP & General Counsel in NOVEN PHARMACEUTICALS INC ($NOVN) and in MABVAX THERAPEUTICS HOLDINGS, INC. ($MBVX) and CEO in Xenetic Biosciences, Inc. ($XBIO) and Chief Executive Officer in Xenetic Biosciences, Inc. ($XBIO) and COO in Xenetic Biosciences, Inc. ($XBIO).
JEFFREY F EISENBERG in Xenetic Biosciences, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of JEFFREY F EISENBERG: Chief Executive Officer, CEO, COO
Holdings: 50,000 shares
Current Value: $227,500
Latest Transaction: Mar 22 2021
$XBIO Market Capitalization: $38.54M
$XBIO Previous Close: $4.55
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of JEFFREY F EISENBERG in Xenetic Biosciences, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, MBVX, NOVN, XBIO
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 22 2021 | XBIO | Xenetic Bioscience ... | EISENBERG JEFFREY F | Chief Executive Off ... | Option Exercise | A | 2.60 | 100,000 | 260,000 | 100,000 | |
| Dec 06 2019 | XBIO | Xenetic Bioscience ... | EISENBERG JEFFREY F | Chief Executive Off ... | Option Exercise | A | 1.31 | 230,000 | 301,300 | 230,000 | |
| Oct 30 2017 | XBIO | Xenetic Bioscience ... | EISENBERG JEFFREY F | CEO | Option Exercise | A | 2.11 | 250,000 | 527,500 | 250,000 | |
| Oct 30 2017 | XBIO | Xenetic Bioscience ... | EISENBERG JEFFREY F | CEO | Grant | A | 0.00 | 50,000 | 0 | 50,000 | 0 to 50 K |
| Dec 06 2016 | XBIO | Xenetic Bioscience ... | EISENBERG JEFFREY F | COO | Option Exercise | A | 3.40 | 75,100 | 255,340 | 230,000 | |
| Dec 06 2016 | XBIO | Xenetic Bioscience ... | EISENBERG JEFFREY F | COO | Option Exercise | A | 3.40 | 75,100 | 255,340 | 154,900 | |
| Dec 06 2016 | XBIO | Xenetic Bioscience ... | EISENBERG JEFFREY F | COO | Option Exercise | A | 3.40 | 75,100 | 255,340 | 79,800 | |
| Dec 06 2016 | XBIO | Xenetic Bioscience ... | EISENBERG JEFFREY F | COO | Option Exercise | A | 3.40 | 4,700 | 15,980 | 4,700 |
Page: 1